Dermal Fillers and Rejuvenation
Botox for Hyperhidrosis
When antiperspirants fail, Botox can be used therapeutically to treat Hyperhidrosis (excessive underarm sweating).
Botox® Neurotoxin treatment helps control excessive underarm sweating by temporarily blocking the chemical signals from the nerves that stimulate the sweat glands. When the signals stop, so does the sweating.
The actual treatment takes 15-20 minutes. A small amount of Botox is injected into several areas of the affected underarm through a very fine needle. You should notice a significant reduction in your hyperhidrosis within four to five days with maximum effects felt up to four weeks from the initial day of treatment.
91% of Botox® hyperhidrosis patients achieved at least a 50% reduction in axillary sweating. Botox® neurotoxin treatment is not a cure; symptoms will gradually return. You and your doctor will know when the time is right for your next treatment. The average duration of response is seven to eight months. Most patients return once per year for another hyperhidrosis treatment.
Neurotoxins for Facial Aesthetics
Use Botox or Xeomin to eliminate or minimize facial wrinkles. These medications are approved to treat the glabella, (11's), the Crow's feet. Off label use of these medications are used to treat the forehead, nose lines, chin dimpling, platysmal bands of the neck as well as the sweat glands in the axila
Latisse (bimatoprost ophthalmic solution) 0.03%
Latisse is a prescription treatment for hypotrichosis (inadequate or not enough lashes), used to grow eyelashes longer, fuller and darker.
Important Safety Information:
If you use/used prescription products for eye pressure problems, use Latisse under doctor care. Latisse may cause increased brown pigmentation of the colored part of the eye, which is likely permanent. Eyelid skin darkening may occur and may be reversible. Only apply at the base of upper lashes. DO NOT APPLY to lower lid. Hair may grow on skin that Latisse frequently touches. If you have eye problems/surgery, consult your doctor about use of Latisse. Common side effects are itchy and red eyes. If discontinued, lashes gradually return to previous appearance.
You are encouraged to report negative side effects of prescription drugs to the FDA.
Appointments are available now!
1. Hom DB, Linzie BM, Huang TC. The healing effects of autologous platelet gel onacute human skin wounds.
Arch Facial Plast Surg. 2007;9(3):174-183.
2. Sclafani AP, Romo TR III, Ukrainsky G, et al. Modulation of wound response and
soft tissue ingrowth in synthetic and allogeneic implants with platelet concentrate. Arch Facial Plast Surg.
3. O’Connell SM, Impeduglia T, Hessler K, Wang XJ, Carroll RJ, Dardik H. Autologous
platelet-rich fibrin matrix as cell therapy in the healing of chronic lowerextremity ulcers. Wound Repair Regen.
4. Cervelli, Valerio MD; Lucarini, Lucilla MD.Use of Platelet-
Rich Plasma and Hyaluronic Acid in the Loss of Substance with
Bone Exposure. Advances in Skin & Wound Care: April 2011 –
Volume 24 – Issue 4 – pp 176-181 [This one shows using the same
techniques used in the Vampire Facelift (R) procedure to grow
new skin WHERE THERE IS NO SKIN]
5. Redaelli, Alessio. Face and neck revitalization with Platelet-
rich plasma (PRP): clinical outcome in a series of 23
consecutively treated patients. Journal of Drugs in Dermatology –
May 1, 2010.
6. Azzena B, Mazzoleni F, Abatangelo G, Zavan B, Vindigni V.
Autologous plateletrich [Using Regen prepared platelet-derived
growth factors (a single-spin centrifuge) to rejuvenate the face
& neck] plasma as an adipocyte in vivo delivery system: case
report. Aesthetic Plast Surg. 2008;32(1):155-161.
7. Cervelli V, Gentile P, Grimaldi M. Regenerative surgery: use of fat grafting combined
with platelet-rich plasma for chronic lower-extremity ulcers. Aesthetic Plast Surg. 2009;33(3):340-345.
8. Cervelli V, Palla L, Pascali M, De Angelis B, Curcio BC, Gentile P. Autologous
platelet-rich plasma mixed with purified fat graft in aesthetic plastic surgery. Aesthetic Plast Surg.
9. Cervelli V, Gentile P. Use of cell fat mixed with platelet gel in progressive hemifacial atrophy. Aesthetic
Plast Surg. 2009;33(1):22-27.
10. Cervelli V, Gentile P, Scioli MG, et al. Application of platelet-rich plasma in plas-tic surgery: clinical and in
vitro evaluation. Tissue Eng Part C Methods. 2009; 15:1-9.
11. Sclafani AP. Platelet-rich fibrin matrix for improvement of deep nasolabial folds. J Cosmet Dermatol.
12. Sclafani AP. Applications of platelet-rich fibrin matrix in facial plastic surgery. Facial Plast Surg.
13. Sclafani AP. Safety, efficacy, and utility of platelet-rich fibrin matrix in facial plastic surgery [published online
February 21, 2011]. Arch Facial Plast Surg. 2011;13(4):247-251.
14. Kakudo N, Minakata T, Mitsui T, Kushida S, Notodihardjo FZ, Kusumoto K. Proliferation-promoting effect
of platelet-rich plasma on human adiposederived stem cells and human dermal fibroblasts. Plast Reconstr Surg.
15. Oh DS, Cheon YW, Jeon YR, Lew DH. Activated platelet-rich plasma improves fat graft survival in nude mice: a
pilot study. Dermatol Surg. 2011;37(5):619-625.
16. Danielsen P, Jørgensen B, Karlsmark T, Jorgensen LN, Agren MS. Effect of topical autologous platelet-rich
fibrin versus no intervention on epithelialization of donor sites and meshed split-thickness skin autografts: a
randomized clinical trial. Plast Reconstr Surg. 2008;122(5):1431-1440.
17. Anitua E, Sa´nchez M, Zalduendo MM, et al. Fibroblastic response to treatment with different preparations
rich in growth factors. Cell Prolif. 2009;42(2):162-170.
18. Carroll RJ, Arnoczky SP, Graham S, O’Connell SM. Characterization of Autologous Growth Factors in Cascade
Platelet-Rich Fibrin Matrix (PRFM). Edison, NJ:Musculoskeletal Transplant Foundation; 2005. Publication
No. 128-XM 307C5.
19. Anthony P. Sclafani, MD; Steven A. McCormick, MD. Induction of Dermal Collagenesis, Angiogenesis, and
Adipogenesis in Human Skin by Injection of Platelet-Rich Fibrin Matrix. Arch Facial Plast Surg. Published online
October 17, 2011. [Biopsy-proven new blood vessel growth and new collegen using platelet-derived growth factors
(using a single-spin centrifuge)]